Intelligent Bio Solutions Inc (INBS): יחס שווי פעילות לרווח לפני ריבית, מסים ופחת
The development of Intelligent Bio Solutions (INBS) is constrained by device certification challenges and potential claims regarding the quality of rapid tests. Business success relies on the accuracy of non-invasive diagnostics and the willingness of companies to implement portable fingerprint scanners. This price chart, where the indicator stands at 0.00, highlights financial instability driven by a liquidity shortage and high product promotion expenses, forcing the company to raise external capital.
פילוחי מדדים מקיפים ואנליטיקה עבור ibs.inc (INBS)
The EV/EBITDA multiple compares the total enterprise value of Intelligent Bio Solutions (INBS) to its operating profit before depreciation, taxes, and interest, allowing for an assessment of the business's real value regardless of its debt load. By analyzing the current EV/EBITDA multiple of the business on GURU.Markets, an investor can determine the extent to which the market is overvaluing the potential of non-invasive fingerprint diagnostics amid shifting credit rates.
